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Immunophilins, including FK506-binding proteins
(FKBPs), are protein chaperones with peptidyl-prolyl
isomerase (PPIase) activity. Initially identified as
pharmacological receptors for immunosuppressants
to regulate immune responses via isomerase-
independent mechanisms, FKBPs are most highly
expressed in the nervous system, where their physi-
ological function as isomerases remains unknown.
We demonstrate that FKBP12 and FKBP52 catalyze
cis/trans isomerization of regions of TRPC1 impli-
cated in controlling channel opening. FKBP52 medi-
ates stimulus-dependent TRPC1 gating through
isomerization, which is required for chemotropic
turning of neuronal growth cones to netrin-1 and
myelin-associated glycoprotein and for netrin-1/
DCC-dependent midline axon guidance of commis-
sural interneurons in the developing spinal cord. By
contrast, FKBP12 mediates spontaneous opening
of TRPC1 through isomerization and is not required
for growth cone responses to netrin-1. Our study
demonstrates a novel physiological function of pro-
line isomerases in chemotropic nerve guidance
through TRPC1 gating and may have significant
implication in clinical applications of immunophilin-
related therapeutic drugs.
INTRODUCTION
FK506-binding proteins (FKBPs) and cyclosporine-binding
cyclophilins are immunophilins with peptidyl-prolyl isomerase
(PPIase) activity (Barik, 2006; Fischer et al., 1989; Gothel and
Marahiel, 1999; Harding et al., 1989; Siekierka et al., 1989;
Snyder et al., 1998; Takahashi et al., 1989). These isomerasescatalyze the isomerization of prolyl-peptide bonds between cis
and trans conformation, which can be a rate-limiting process
that influences protein folding and function (Gothel andMarahiel,
1999). Immunophilins were originally discovered as biological
receptors for commonly used immunosuppressant drugs
FK506 (Harding et al., 1989; Siekierka et al., 1989) and cyclo-
sporine A (Fischer et al., 1989; Takahashi et al., 1989), respec-
tively. Though both cyclosporine A and FK506 inhibit the PPIase
activity of immunophilins, their immunosuppressive function is
isomerase activity independent and instead results from inhibi-
tion of calcineurin by the cyclophilins-cyclosporine A or FKBP-
FK506 complex (Liu et al., 1991). Interestingly, FKBPs are 10 to
50 times more enriched in the nervous system than in the
immune system (Steiner et al., 1992). Previously, limited studies
of FKBPs in the nervous system have been largely focused on
their roles as calcineurin inhibitors in association with FK506
and as protein chaperones, functions that are independent of
the isomerase activity (Barik, 2006; Snyder et al., 1998). While
important in clinical applications, these drug-dependent gain-
of-function properties of FKBPs are not indicative of the physio-
logical relevance since mammalian cells do not naturally
encounter immunosuppressant drugs. The endogenous cellular
functions of PPIases and their substrates in the nervous system
remain elusive.
Advances in the medicinal chemistry of FK506 have led to the
discovery of agents that specifically inhibit the PPIase activity of
FKBPs but do not inhibit calcineurin. These compounds, such as
GPI-1046, while not immunosuppressive, provide a tool to
examine the physiological function of FKBPs as isomerases
independent of calcineurin. GPI-1046 was reported to enhance
neuronal outgrowth following injury (Burnett and Becker, 2004;
Guo et al., 2001). Despite their initial promise, the utility of these
compounds has been limited, in part because of the uncertainty
of their molecular target and basis of action. Notably, there is
a poor correlation between the efficacy of inhibiting the PPIase
activity of FKBP12 and promotion of axonal outgrowth (Gold
et al., 1999). Moreover, the efficacy of PPIase inhibitors is not
diminished in neurons cultured from FKBP12 knockout miceNeuron 64, 471–483, November 25, 2009 ª2009 Elsevier Inc. 471
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GPI-1046 was also reported to protect neurons from lethal
effects of HIV-1 proteins TAT and gp120 by reducing the Ca2+
load in endoplasmic reticulum, suggesting a link with Ca2+
signaling (Caporello et al., 2006).
The FKBP family member FKBP52 recently has been reported
to bind TRPC1 cation channels (Sinkins et al., 2004). FKBP52 is
similar to FKBP12 in that it contains an N-terminal PPIase
domain that binds FK506 and GPI-1046, but it also possesses
a second PPIase-like domain that lacks catalytic activity, three
tetratricopeptide repeat domains that mediate specific protein
interactions, and a C-terminal calmodulin binding site (Davies
and Sanchez, 2005). TRPCs are six membrane spanning cation
channels that belong to the TRP superfamily of proteins, which
mediate diverse cellular sensory responses (Clapham, 2003;
Nilius et al., 2007; Venkatachalam and Montell, 2007). Notably,
TRPC1 mediates Ca2+ influx and subsequent growth cone
turning responses to netrin-1 in vitro (Shim et al., 2005; Wang
and Poo, 2005) and is required for midline axon guidance of
commissural interneurons in the developing spinal cord in vivo
(Shim et al., 2005). TRPC1-dependent Ca2+ signaling has also
been implicated in mediating neuronal responses to myelin
and glia scar-associated inhibitors that prevent axonal regener-
ation in the adult central nervous system and is necessary for
growth cone responses of Xenopus spinal neurons to myelin-
associated glycoprotein (MAG) (Shim et al., 2005). In support
of a role for FKBPs in TRPC channel opening, FK506 disrupts
FKBP-TRPC binding and inhibits TRPC6 channel activity
(Sinkins et al., 2004). Since FK506 disrupts both the binding
and PPIase activity, and also inhibits calcineurin, the mechanism
by which FKBPs contribute to TRPC channel gating remains
unknown. In Drosophila, an FKBP52 homolog associates with
TRPL and inhibits Ca2+ influx (Goel et al., 2001). FKBP52 also
inhibits TRPV5 activation and subsequent Ca2+ influx when
coexpressed in HEK293 cells (Gkika et al., 2006). The role of
FKBP isomerases in regulating TRP channels, in particular their
PPIase function in vivo, remains to be determined.
In considering how FKBPs might impact the TRPC1 function,
we noted that the C-terminal region of TRPC1 implicated in
FKBP52 binding overlaps with the sites of physical interaction
with Homer (Yuan et al., 2003) and STIM1 (Huang et al., 2006;
Zeng et al., 2008), which regulate the gating of TRPC1. Homer
binding to TRP box 2 (Figure 1A) is essential for normal gating
of TRPC1 and, in combination with its ability to self-associate
and bind a second site in the N terminus of TRPC1, Homer main-
tains the channel in a closed state that can be activated by G
protein receptors or depletion of intracellular Ca2+ stores (Yuan
et al., 2003). Moreover, the two aspartate residues immediately
N-terminal to TRP box 2 associate with the C terminus of
STIM1 to open the channel in response to depletion of intracel-
lular Ca2+ stores (Zeng et al., 2008). The presence of the putative
FKBP52 binding site in regions critical for TRPC1 gating sug-
gested a possible role for FKBP52 in channel opening. Here,
we report that FKBP52 regulates the agonist-dependent
opening of TRPC1 channels, whereas FKBP12 stimulates spon-
taneous opening, both in a PPIase-dependent fashion. Further-
more, FKBP52 PPIase activity is selectively required for normal
growth cone responses to specific guidance cues both in vitro472 Neuron 64, 471–483, November 25, 2009 ª2009 Elsevier Inc.and in vivo. Our study demonstrates a novel function of PPIases
in chemotropic nerve guidance through gating of TRPC1 channel
activity.
RESULTS
FKBP52 Binds Regions of TRPC1 that Are Important
for Channel Gating
To explore the role of FKBPs in regulating TRPC1 channel func-
tion, we first examined binding between FKBPs and TRPC1. As
reported previously (Sinkins et al., 2004), TRPC1-WT (wild-type)
coimmunoprecipitated (co-IP) with native FKBP52 in HEK293
cells (Figure 1B). Point mutations of TRPC1 in the TRP box 2,
including TRPC1-P645L, P646L, and F648R, disrupted the
co-IP of TRPC1 with FKBP52 (Figures 1A and 1B). The depen-
dence of binding upon P645 is consistent with the consensus
binding site for the FKBP family PPIases that typically includes
a hydrophobic amino acid (L644) followed by a proline
(Schiene-Fischer and Yu, 2001). TRPC1mutationswith defective
FKBP52 binding also disrupted their binding to Homer 3 (H3;
Figure 1B), suggesting that FKBP52 and Homer bind to the
same region in TRPC1. We also identified point mutations of
TRPC1 that bound FKBP52 but not Homer (including TRPC1-
L644S, L644A, and P645A; Figure 1B), suggesting that they
have overlapping but distinct sites of interaction. Alternatively,
the TRPC1-P645A mutant may create a new binding site for
FKBP52 due to the presence of P645A-646P. We did not identify
TRPC1 mutants that bound Homer but not FKBP52.
The N-terminal Homer binding site also includes a consensus
sequence for FKBP interaction (Figure 1A). Point mutations in the
N terminus of the full-length TRPC1 that disrupt its co-IP with
Homer (Yuan et al., 2003) did not alter TRPC1 co-IP with
FKBP52 (Figure S1). Since FKBP52 binding to the C terminus
of TRPC1 could obscure effects of mutations in the N terminus,
we repeated binding studies using an N-terminal fragment
of TRPC1 (TRPC1-NT). Pull-down experiments showed that
GST-FKBP52 bound WT-TRPC1-NT (Figure 1C). Analysis of
mutations of TRPC1 revealed that TRPC1-NT-P23A bound
GST-FKBP52, whereas TRPC1-NT-L19A and TRPC1-NT-P20A
did not. These results indicate that, similar to the C-terminal
region, FKBP52 and Homer bind overlapping but distinct sites
in the N-terminal region of TRPC1. In contrast to FKBP52, we
did not detect FKBP12 binding to TRPC1 using co-IP or GST
pull-down assays (data not shown).
FKBP12 and FKBP52 Catalyze cis/trans Isomerization
of L-P Bonds in N- and C-Terminal Sequences of TRPC1
To directly examinewhether FKBPs catalyze cis/trans isomeriza-
tion of regions of TRPC1 that are implicated in channel opening,
we used nuclearmagnetic resonance (NMR) exchange spectros-
copy to identify conformational exchange processes between
states with different chemical shifts that occur in a 0.1–10 s
time regime (Macura et al., 1994; Perrin and Dwyer, 1990),
including cis/trans isomerization (Bosco et al., 2002; Kern
et al., 1993). We generated 15N-labeled TRPC1(14-30) and
TRPC1(635-656) peptides that include the FKBP52 binding sites
from N and C termini of TRPC1, respectively. Due to the spectral
overlap, TRPC1(14-30) had to be specifically 15N labeled at the
Neuron
PPIase FKBP52 Controls Axon Guidance through TRPC1Figure 1. Binding and Isomerization of TRPC1 by FKBP52 and FKBP12
(A) A schematic diagram of human TRPC1 indicating regions critical for FKBP52 (19LPSSP23 and 644LPPPF648) and C-terminal Homer binding (645PPPF648).
(B) FKBP52 and Homer require similar, but not identical, sequences of TRPC1 C terminus for binding. Lysates of HEK293 cells expressing HA-TRPC1 constructs
(C1) were assayed for co-IP with native FKBP52 or Homer 3 (H3).
(C) FKBP52 binds TRPC1 N terminus (NT) and requires canonical Leu-Pro residues for binding. Lysates of HEK293 cells expressing HA-TRPC1 NT constructs
were assayed for binding to GST-FKBP52.
(D) Catalysis of L19-P20 and L644-P645 peptidyl-prolyl bonds in TRPC1 mimic peptides by substoichiometric amounts of FKBP12 and FKBP52. Expansion
of 1H-15N heteronuclear exchange spectra at 25C showing amide signals of cis and trans isomers of L19 and L644 residues within TRPC1(14-30) and
TRPC1(535-656) peptides, respectively. Conformational exchange between cis and trans isomers was slow on the NMR timescale (kex < 0.1 s
1) in absence
of FKBPs, resulting in distinct resonance signals for the two conformations (left). Upon addition of catalytic amounts of either FKBP12 or FKBP52 [30:1
TRPC1(635-656)/FKBP and 133:1 TRPC1(14-30)/FKBP], exchange peaks were observed connecting the cis and trans isomer resonances, denoted by dashed
lines, indicating efficient acceleration of the isomerization rate by the enzymes.single Leu residue only, while TRPC1(635-656) was uniformly 15N
labeled.
Isomerization around L-P bonds corresponding to the L19-
P20 and L644-P645 positions in the full-length TRPC1 was
slow on the NMR timescale (<0.1 s1), as shown by distinct
amide resonance signals corresponding to cis and trans confor-
mations in 1:10 ratio consistent with thermodynamically
expected distribution of the two conformers for an unstructured
peptide (Reimer et al., 1997) (Figure 1D). To assess the effect
of FKBPs on TRPC1, we performed two-dimentional 1H-15N
heteronuclear exchange experiments (Farrow et al., 1994) on
15N-labeled TRPC1(14-30) and TRPC1(635-656) peptides in
the presence of catalytic amounts of recombinant FKBP12 or
FKBP52. Addition of FKBP12 or FKBP52 to either peptide
resulted in the appearance of exchange peaks connecting L19
and L644 cis and trans auto peaks, and a corresponding reduc-
tion in the intensity of the auto peaks (Figure 1D). These results
demonstrated that both FKBP12 and FKBP52 efficiently catalyze
the cis/trans isomerization about L-P bonds in N- and C-terminalregions of TRPC, with the N-terminal site being catalyzed
with >4.5-fold efficiency relative to the C-terminal site. It is
notable that FKBP12 was catalytically effective despite the
absence of biochemically defined binding in co-IP or GST pull-
down assays, which is consistent with the notion that catalysis
does not require high-affinity binding.
We also used NMR to evaluate point mutants FKBP12-D37L
and FKBP52-FD67DV for their ability to catalyze isomerization
of TRPC1 peptides (Figure S2). Both mutants have been previ-
ously reported to possess reduced catalytic activity toward
artificial substrates (Barent et al., 1998; Tradler et al., 1997).
Addition of either of the FKBP mutants at molar ratios as high
as 1:5 relative to the TRPC1 peptides, which was significantly
higher than those used with WT FKBPs, failed to produce signif-
icant exchange, indicating at least an order of magnitude reduc-
tion in catalytic activity relative to WT FKBPs (Figure S2). In
biochemical assays, FKBP52-FD67DV bound TRPC1 N- and
C-terminal regions similarly to FKBP52-WT, and like FKBP12-
WT, FKBP12-D37L did not bind TRPC1 (data not shown).Neuron 64, 471–483, November 25, 2009 ª2009 Elsevier Inc. 473
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(A–C) Sample traces of electrophysiology recordings of TRPC1 currents. HEK293 cells transfected with TRPC1 and empty vector (A), TRPC1 and FKBP12-WT
(B) or FKBP12-D37L) (,) (B), TRPC1 and FKBP52-WT (6) or FKBP52-FD67DV (-) (C) were bathed in media containing 140 mM Na+, then stimulated with 100
mM carbachol and finally incubated in Na+-free media to determine the zero current.
(D) Summary of the spontaneous, receptor-activated and total current. Values represent mean ± SEM (*p < 0.01, Student’s t test).
(E) Agonist-stimulated currents of select TRPC1 mutants were restored by coexpression of FKBP52. HEK293 cells were transfected with TRPC1-WT and the
indicated TRPC1 mutants alone or together with FKBP52. Values represent mean ± SEM (n = 4–5) of the total, spontaneous, and agonist-stimulated current
(*p < 0.01, Student’s t test).Taken together, these results identified TRPC1 as an endoge-
nous PPIase substrate of FKBP52 and FKBP12.
FKBP52 and FKBP12 PPIase Activity Differentially
Regulate TRPC1 Channel Opening
We next examined the role of FKBPs on TRPC1 channel gating
using electrophysiology. To distinguish between effects of
binding versus PPIase activity, we included FKBP52-FD67DV
and FKBP12-D37L in our assays. Initial analysis determined
that WT and PPIase-inactive FKBPs did not substantially alter
TRPC1 trafficking to the plasma membrane of HEK293 cells.
Both WT and PPIase-inactive mutants of FKBPs increased
surface TRPC1 by 2-fold (Figure S3). FKBP transgene expres-
sion did not alter the physical association of TRPC1 with IP3R
(Figure S3), which has been implicated in channel opening
(Kiselyov et al., 1999). Similarly, FKBPs did not alter the associ-
ation of Homer and IP3R (Figure S3), which may be important for
internal Ca2+ release (Mikoshiba, 2007). Recordings of TRPC1
currents from the same preparation, however, showed striking
differences in the spontaneous and agonist-induced currents
(Figure 2). In the absence of FKBP transgene, TRPC1 produced
a small spontaneous current (with a nearly linear I/V) that
increased 4-fold upon stimulation of transfected M3 receptors474 Neuron 64, 471–483, November 25, 2009 ª2009 Elsevier Inc.with 100 mM carbachol (Figures 2A and 2D). Coexpression of
FKBP12 resulted in 2-fold increase in the total current, most
of which was spontaneously active and was not further
increased by stimulation with carbachol (Figures 2B and 2D).
Coexpression of FKBP52 also resulted in 2.5-fold increase of
the total current (Figures 2C and 2D). In contrast to FKBP12,
the major effect of FKBP52 was to increase the agonist-stimu-
lated current with little effect on the spontaneous current (Figures
2C and 2D). Notably, effects of both FKBPs were dependent on
their PPIase activity, since FKBP12-D37L and FKBP52-FD67DV
blocked both spontaneous and carbachol-induced currents
(Figures 2B–2D). These observations indicate that FKBP52
amplifies the receptor-regulated activity of TRPC1 channel in
a PPIase activity-dependent fashion.
To gain further insight into the molecular mechanism of
FKBP52 in TRPC1 channel opening, we monitored its action on
a panel of TRPC1 mutants. TRPC1-P23A, which binds FKBP52
but not Homer (Figures 1C and S1), showed a large spontaneous
current with little agonist-stimulated response (Figure 2E),
consistent with a model in which Homer must bind to both the
N- and C-terminal sequences to prevent spontaneous channel
activity (Yuan et al., 2003). Overexpression of FKBP52 resulted
in a reduction of spontaneous current and an increase of
Neuron
PPIase FKBP52 Controls Axon Guidance through TRPC1agonist-stimulated current. This result is consistent with the
notion that FKBP52, like Homer, can prevent spontaneous
channel activity by binding both N and C termini of TRPC1. Simi-
larly, TRPC1-P645A, which binds FKBP52 but exhibits reduced
binding to Homer (Figure 1B), showed large spontaneous and
low agonist-stimulated current and was restored to near WT
function by overexpression of FKBP52 (Figure 2E). By contrast,
TRPC1-F648R, which does not bind Homer or FKBP52, showed
a large spontaneous current that was not altered upon overex-
pressionof FKBP52 (Figure 2E). Like FKBP52, FKBP12 increased
the total current of TRPC1-WT; however, FKBP12 did not reduce
spontaneous current or restore agonist-stimulated channel
properties to TRPC1-P23A or TRPC1-P645A (data not shown).
Since FKBP12 does not bind TRPC1 in biochemical assays, the
differential effects of FKBP52 and FKBP12 are consistent with
a model that FKBP52 binding to both N and C termini of TRPC1
Figure 3. PPIase-Dependent Regulation of Netrin-1-
Induced Ca2+ Influx by FKBP52
(A–C) Bright-field and fluorescence images of growth cones of
Xenopus spinal neurons loaded with Fluo-4 at different time
points after stimulation with netrin-1 (10 ng/ml). Sample
images show neurons from an uninjected embryo without
(control, A) or with GPI-1046 (500 nM, B) in the bath or from
an FKBP52-FD67DV-expressing neuron (C). Pseudocolor
indicates Ca2+ levels, with red as the highest and blue as the
lowest. Scale bar, 10 mm.
(D) Time course of netrin-1-induced Ca2+ rise in growth cones
under different conditions. The fluorescence intensity of each
time point was normalized to the average fluorescence
intensity of 5 min baseline period before netrin-1 application
for each neuron. Values represent mean ± SEM (n = 8–11;
*p < 0.01, bootstrap test).
(E) Summary of netrin-1-induced Ca2+ changes in growth
cones. The fluorescence intensity was normalized to the
average fluorescence intensity of 5 min baseline levels
prior to the netrin-1 application (5 ng/ml). Values represent
mean ± SEM (*p < 0.01, bootstrap test).
is required to prevent spontaneous channel activity.
Importantly, restoration of the mutant channel
activity by FKBP52-WT, but not FKBP52-FD67DV,
further suggests an essential role for PPIase activity
for TRPC1 channel opening.
Netrin-1-Induced Ca2+ Rise in Neuronal
Growth Cones Requires PPIase Activity
of FKBP52
FKBP52 is highly expressed in the developing
nervous system of Xenopus embryos (Figure S4A)
and is conserved across vertebrate species
(Figure S4B). Xenopus TRPC1 (XTRPC1) is a critical
mediator of netrin-1-induced Ca2+ influx and
attractive growth cone guidance (Shim et al.,
2005;Wang and Poo, 2005). As reported previously
(Ming et al., 2002; Wang and Poo, 2005), netrin-1
induced significant rise of intracellular Ca2+
([Ca2+]i) within growth cones of cultured Xenopus
spinal neurons (Figures 3A, 3D, and 3E). This
[Ca2+]i rise requires netrin-1 receptor DCC, since a specific mor-
pholino against Xenopus DCC (XDCC-MO) abolished the netrin-
1-induced [Ca2+]i rise (Figures 3D and 3E). Inhibition of PPIase
activity by GPI-1046 (Figure 3B) or expression of FKBP52-
FD67DV (Figure 3C) also abolished netrin-1-induced [Ca2+]i
rise in growth cones (Figures 3D and 3E). Furthermore, overex-
pression of TRPC1-P645L, which is constitutively active (Yuan
et al., 2003), prevented the ability of netrin-1 to evoke an increase
of [Ca2+]i (Figure 3E), consistent with the electrophysiology result
that the constitutive activity of TRPC1-P645L cannot be
increased by agonist stimulation (Yuan et al., 2003).
Netrin-1-Induced Attractive Growth Cone Turning
Requires PPIase Activity of FKBP52
Ligand-induced Ca2+ influx in the growth cone is essential
for guidance responses to a group of guidance cues (HongNeuron 64, 471–483, November 25, 2009 ª2009 Elsevier Inc. 475
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Regulation of Netrin-1-Induced Attractive
Growth Cone Turning Responses of Xeno-
pus Spinal Neurons by FKBP52
(A–D) Growth cone turning responses in a gradient
of netrin-1 by neurons in the control medium (A), in
the presence of bath application of FK506 (10 nM,
B) or GPI-1046 (10 nM, C), and neurons derived
from embryos injected with the mRNA encoding
FKBP52-FD67DV (D), respectively. The left two
columns of images show growth cones at the
start (0 min) and the end of exposure (30 min) in
a netrin-1 gradient (10 mg/ml in the pipette). Scale
bar, 20 mm. The right column shows superimposed
trajectories of neurite extension during the 30 min
period for a sample population of 12 neurons
under each condition. The origin is the center of
the growth cone, and the original direction of
growth is vertical. Arrows indicate the direction
of the gradient. Scale bar, 10 mm.
(E) The PPIase activity is required for netrin-
1-induced growth cone attraction. Shown is the
summary of turning angles under different condi-
tions. Values represent mean ± SEM (*p < 0.01,
bootstrap test).
(F) FKBP52 regulates netrin-1-induced growth
cone turning through its association with TRPC1.
Values represent mean ± SEM (*p < 0.01, boot-
strap test).
(G and H) Netrin-1-induced PPIase activation is
sufficient for attractive growth cone turning.
Shown in (G) is a schematic illustration of experi-
mental paradigms and models. Netrin-1, orange;
PPIase activity, gray; GPI-1046, blue). Similar as
in (A)–(D), shown in (H) are growth cone turning
responses in a gradient of GPI-1046 (100 mM in
the petite) in the normal medium or with netrin-1
(10 ng/ml) in the bath.et al., 2000; Zheng, 2000). We assessed the functional role of
FKBP52 in axon guidance using a well-established in vitro
growth cone turning assay (Lohof et al., 1992; Ming et al.,
1997, 2002; Song et al., 1998; Zheng et al., 1994). In a micro-
scopic gradient of netrin-1, Xenopus spinal neurons exhibited
chemoattractive growth cone turning responses (Figure 4A).
When these growth cones were exposed to a netrin-1 gradient
in the presence of FK506 or GPI-1046, attractive growth cone
turning responses were completely abolished (Figures 4B, 4C,
and 4E), consistent with their inhibition of netrin-1-induced
[Ca2+]i rise (Figure 3). Similarly, expression of FKBP52-FD67DV,
but not FKBP52-WT, blocked netrin-1-induced attraction (Fig-
ures 4D and 4E). Furthermore, specific morpholinos against
Xenopus FKBP-52 (XFKBP52-MO), but not a control morpholino,
blocked attractive growth cone turning responses to netrin-1
(Figure S5). Thus, FKBP52 PPIase activity is required for ne-
trin-1-induced attraction.
We sought to determine whether the action of FKBP52 on
TRPC1 is required for mediating netrin-1-induced attraction or
whether they only create a permissive condition for a different
signal to induce turning. We noted that axons continued to
grow in the presence of FKBP inhibitors or with expression of
FKBP and TRPC mutants that blocked attractive responses to476 Neuron 64, 471–483, November 25, 2009 ª2009 Elsevier Inc.netrin-1, indicating that general axonal growth was not impaired.
Next, we examined effects of expression of TRPC1-P645L and
TRPC1-P645A. Since both of these channels are constitutively
open, if the action of FKBP52 on the opening of TRPC1 provides
a permissive condition, both channels would be expected to
support attractive responses. However, expression of either
TRPC1-P645L or TRPC1-P645A abolished netrin-1-induced
attraction (Figure 4F). Moreover, overexpression of FKBP52-
WT with TRPC1-P645A rescued netrin-1-induced attraction
(Figure 4F), in a manner that parallels FKBP52-dependent
conversion of TRPC1-P645A constitutive activity to induced
activity in HEK293 cells (Figure 2E). These data support a model
in which FKBP52 action on TRPC1 is required for netrin-1-
induced attraction, instead of a permissive role. Interestingly,
expression of FKBP12-WT or FKBP12-D37L did not affect
attractive turning responses to a netrin-1 gradient (Figure S6),
which reinforces the specific role of FKBP52 and TRPC1 activity
in netrin-1 signaling.
Growth cone chemoattraction requires a local gradient of
a ligand that is thought to differentially activate receptors
and downstream signal cascades for the biased growth toward
higher concentration gradient (Figure 4G) (Ming, 2006). If the
PPIase activity of FKBP52 is sufficient for the signaling output
Neuron
PPIase FKBP52 Controls Axon Guidance through TRPC1of netrin-1, then our model predicts that a local gradient of
PPIase activator should be able to induce attractive turning
responses even in the absence of a netrin-1 gradient. The
model further predicts that growth cones should turn away
from a local PPIase inhibitor gradient in the presence of
uniform activation of PPIase activity by bath application of
netirn-1, given netrin receptor-dependent PPIase signaling
should be reduced on the side facing higher concentration of
inhibitors (Figure 4G). Because of a lack of specific PPIase
activators, we tested our model using PPIase inhibitor GPI-
1046. We subjected growth cones to a gradient of GPI-1046
(100 mM in the pipette) with concurrent, uniform netrin-1 acti-
vation (10 ng/ml in the bath). Consistent with the model,
neuronal growth cones exhibited significant turning responses
away from the PPIase inhibitor (Figure 4H). This effect was
not due to the general inhibition of axonal outgrowth by GPI-
1046, since neurons in the same GPI-1046 gradient without
uniform netrin-1 stimulation exhibited no change in the growth
rate and importantly, no bias in the direction of growth cone
extension (Figure 4H). Taken together, these results support
the model that FKBP52 and TRPC1 signaling is both neces-
Figure 5. Requirement of PPIase Activity of FKBP52
for Midline Axon Guidance of Commissural Interneur-
ons in the Developing Xenopus Spinal Cord
(A) A schematic diagram of commissural interneuron projec-
tions in the developing embryonic Xenopus spinal cord.
(B–G) Sample images of the sagittal view of commissural inter-
neurons and their axonal projections in the Xenopus spinal
cord from stage 25 embryos. Shown are projections of Z stack
confocal images of 3A10 immunostaining of commissural
interneuron axons from uninjected embryos (control, B), with
treatment of GPI-1046 (0.5 mM, D) or FK506 (0.5 mM, E), or
embryos injected with XDCC-MO (C), FKBP52-WT mRNA
(F), FKBP52-FD67DV mRNA (G), respectively. Arrows point
to axons with defect in projection to the ventral middle line.
Also note axons with premature fasciculation (highlighted
with ‘‘*’’). Scale bar, 40 mm.
(H) Quantification of the percentage of 3A10+ commissural
interneurons with normal midline crossing under different
experimental conditions. Values represent mean ± SEM
(n = 10–20 embryos; *p < 0.01, bootstrap test).
sary and sufficient for netrin-1-induced growth
cone steering in vitro.
FKBP52 and Its Regulation of TRPC1 Are
Essential for Commissural Axon Guidance
In Vivo
We next examined whether PPIase activity of
FKBP52 is required for axon guidance in vivo.
Netrin-1/DCC signaling is known to guide commis-
sural axons to the CNS midline in the developing
spinal cord of mouse (Figure 5A) (Serafini et al.,
1996). To confirm a role for netrin-1/DCC signaling
in development Xenopus spinal cord, we injected
a specific morpholino against XDCC into Xenopus
embryos at the one-cell stage and examined
stage 25 embryos, a time when commissural inter-
neuron axons have already reached the CNS midline (Shim
et al., 2005). Commissural interneuron axons in developing
Xenopus embryos were specifically identified with the 3A10
monoclonal antibody (Moon and Gomez, 2005; Phelps et al.,
1999; Serafini et al., 1996; Shim et al., 2005) (Figure 5B; see
Movie S1). Many of the 3A10+ axons in embryos with XDCC-
MO failed to reach the midline; instead, they joined ipsilateral
tracts or turned longitudinally between the ipsilateral tract and
the midline (Figure 5C; Movie S2). Interestingly, some of the
commissural axons also lost contact avoidance and exhibited
fasciculation prematurely before crossing the midline (Figure 5C)
(Moon and Gomez, 2005). Thus, netrin-1/DCC-dependent mid-
line guidance is functionally conserved in the developing Xeno-
pus embryonic spinal cord.
Next, we applied GPI-1046 or FK506 to developing Xenopus
embryos between stage 22 and 25, a time window when com-
missural interneuron axons are attracted to the midline (Shim
et al., 2005). Such treatments led to significant guidance defects
similar as those with XDCC-MO (Figures 5D, 5E, and 5H). Over-
expression of FKBP52-FD67DV, but not FKBP52-WT, led to
similar midline targeting errors and premature fasciculationNeuron 64, 471–483, November 25, 2009 ª2009 Elsevier Inc. 477
Neuron
PPIase FKBP52 Controls Axon Guidance through TRPC1(Figures 5F–5H; Movie S3). Strikingly, some of the commissural
neurons expressing FKBP52-FD67DV appeared to completely
ignore guidance cues and sent long projections outside of the
spinal cord (Movie S3).
To examine whether the interaction of TRPC1 and FKBP52 is
essential for axon guidance in vivo, we manipulated the expres-
sion of TRPC1 and FKBPs. Consistent with our in vitro findings
from the growth cone turning assay, expression of TRPC1-
P645L or TRPC1-P645A led to significant midline guidance
defects (Figures 6B, 6C, and 6G; Movies S4 and S5), very similar
to those resulting from XDCC knockdown and inhibition of
FKBP52 PPIase activity (Figure 5). Overexpression of FKBP52-
WT, but not FKBP12-WT, largely rescued the guidance defect
by TRPC1-P645A mutation (Figures 6D, 6E, and 6G; Movies
S6 and S7). Also consistent with in vitro results, overexpression
of FKBP12-WT or FKBP12-D37L alone did not result in altered
guidance phenotypes (Figures 6F and 6G), again indicating the
specific role of FKBP52. Taken together, these results demon-
strate that PPIase-dependent regulation of TRPC1 channel
activity specifically by FKBP52 is required for commissural inter-
neuron axon guidance in the developing Xenopus spinal cord
in vivo.
Figure 6. Requirement of Association between TRPC1
and FKBP52, but Not FKBP12, for Midline Axon Guid-
ance of Commissural Interneurons in the Developing
Xenopus Spinal Cord
(A–F) Sample images of the sagittal view of commissural inter-
neurons and their axonal projections in the Xenopus spinal
cord from stage 25 embryos. Shown are projections of Z stack
confocal images of 3A10 immunostaining of commissural
interneuron axons from embryos injected with mRNAs
encoding TRPC1-WT (A), TRPC1-P645L (B), TRPC1-P645A
(C), TRPC1-P645A and FKBP12-WT (D), TRPC1-P645A and
FKBP52-WT (E), and FKBP12-WT (F), respectively. Arrows
point to axons with defect in projection to the ventral middle
line. Also note axons with premature fasciculation (highlighted
with ‘‘*’’). Scale bar, 40 mm.
(G) Quantification of the percentage of 3A10+ commissural
interneurons with normal midline crossing under different
experimental conditions. Values represent mean ± SEM
(n = 10–20 embryos; *p < 0.01, bootstrap test).
Repulsive Growth Cone Responses to MAG,
but Not Sema3A, Requires PPIase Activity
of FKBP52
MAG is a major component of myelin (McKerracher
et al., 1994; Mukhopadhyay et al., 1994), and we
previously showed that MAG-induced repulsion of
growth cones of Xenopus spinal neurons requires
the function of XTRPC1 (Shim et al., 2005). Similar
to Xenopus spinal neurons, axonal growth cones
of rat hippocampal neurons exhibited significant
repulsive turning responses to a MAG gradient
(Figure 7A) (Goh et al., 2008). Interestingly, applica-
tion of GPI-1046 or overexpression of FKBP52-
FD67DV abolished MAG-induced repulsion in
these mammalian neurons (Figures 7A and 7B).
Furthermore, overexpression of TRPC1-P645A,
which shows constitutive channel activity (Figure 2E), blocked
MAG-induced growth cone repulsion (Figures 7A and 7B).
Importantly, coexpression of FKBP52-WT and TRPC1-P645A
rescued MAG-induced repulsion in these neurons (Figure 7B).
Thus, proline isomerization of TRPC1 by FKBP52 is essential
for transducing MAG signaling in mammalian neurons.
To further examine the specificity of PPIase in growth cone
guidance, we examined repulsive turning responses of Xenopus
spinal neurons to a Sema3A gradient, which were known to be
independent Ca2+ and TRPC1 (Shim et al., 2005). Interestingly,
bath application of either FK506 or GPI-1046 exhibited no signif-
icant effects on Sema3A-induced repulsive growth cone turning
responses (Figure 7C). Taken together, these results indicate
that PPIase activity of FKBP52 is selectively required for growth
cone response to guidance cues involving Ca2+ and TRPC1
signaling.
DISCUSSION
Using biochemistry, NMR, electrophysiology, Ca2+ imaging, and
functional axon guidance assay, we demonstrated that the
isomerase activity of FKBP52 regulates neuronal growth cone478 Neuron 64, 471–483, November 25, 2009 ª2009 Elsevier Inc.
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FKBP52 forMAG-Induced, but Not Sema3A-
Induced, Growth Cone Repulsion
(A) Axonal growth cone responses in a gradient
of MAG (150 mg/ml in the pipette) of primary
hippocampal neurons expressing GFP alone
or coexpressing GFP and FKBP52-FD67DV,
TRPC1-P645A, TRPC1-P645A, and FKBP52-WT,
respectively. Images show growth cones at the
start (0 min; middle panel) and the end of expo-
sure (30 min; right panel) in a MAG gradient
(150 mg/ml in the pipette). Also shown are images
of the whole neuron at the end of the assay (left
panel).
(B) Summary of growth cone turning angles of
mammalian hippocampal neurons in response
to a MAG gradient under different conditions.
Values represent mean ± SEM (n = 13–32. *p <
0.01, bootstrap test).
(C) Lack of effects of PPIase inhibitors on Sema
3A-induced growth cone turning. Shown is a
summary of growth cone turning angles of Xenopus spinal neurons in a gradient of Sema3A (50 mg/ml in the pipette) in the absence or presence of GPI-1046
(10 nM) or FK506 (10 nM) in the bath. Values represent mean ± SEM (n = 12–14). Note that no significant differences were found (p < 0.05, bootstrap test).responses to netrin-1 both in vitro and in vivo through regulation
of TRPC1 channel opening. The present finding identifies an
isomerase-dependent physiological and endogenous function
of immunophilins in the biological system in vivo. The PPIase-
dependent molecular mechanism is likely to be broadly relevant
to TRPC channel gating, and we demonstrate that it underlies
attractive neuronal growth cone responses to netrin-1 in Xeno-
pus neurons and repulsive responses to MAG in mammalian
neurons. Both of these responses have been previously charac-
terized to be dependent on [Ca2+]i and TRPC1 (Shim et al., 2005).
In contrast, repulsive growth cone responses to Sema3A, which
were known to be independent of Ca2+ and TRPC1 (Shim et al.,
2005), is not regulated by the PPIase activity. Previous studies
have established that netrin-1 induces an attractive response
upon its binding to DCC,which signals in amanner that is depen-
dent on increased [Ca2+]i, cAMP, activation of phospholipase
C-g (PLC-g), PI3K, MAPK, and Rho GTPases (Song and Poo,
1999). While the mechanism of coupling between DCC and
TRPC1 is not known, PLC-g is implicated in TRPC3 activation
in neuronal growth cone responses to BDNF (Li et al., 2005).
The present study indicates that for its normal function, TRPC1
activation is coupled to netrin-1/DCC signaling via isomerization
by FKBP52, since expression of constitutively active TRPC1
mutants blocked both the netrin-1-induced increase of [Ca2+]i
and growth cone attraction, and these responses were rescued
by coexpression of FKBP52 that restores agonist-dependent
TRPC1 channel activity. Failure of FKBP12 and FKBP12-D37L
to alter netrin-1-dependent responses in neurons contrasts
with experiments in HEK293 cells expressing transgene M3
receptor and TRPC1 and suggests that the native netrin-
1/DCC signaling complex is selective for FKBP52.
Our studies provide novel molecular insight into how FKBP52
might confer agonist-dependent opening of TRPC1. Previous
studies on the regulation of TRPC1 by Homer suggest that
physical interactions linking discrete regions in the N and C
terminus of TRPC1 prevent spontaneous channel activity (Yuanet al., 2003). Disruption of Homer binding, or of Homer’s ability
to self-associate, results in spontaneous TRPC1 channel acti-
vity. FKBP52 binds N- and C-terminal regions of TRPC1 that
overlap with the binding sites for Homer. Like Homer, FKBP52
can dimerize, an activity that is dependent on the N-terminal
PPIase domain (Davies and Sanchez, 2005), and FKBP52 can
restore agonist-dependent channel opening of TRPC1 mutants
that fail to bind Homer. FKBP52 is distinct from Homer in
that it possesses the PPIase activity essential for channel
opening. FKBP52 accelerates isomerization of L-P bonds in
both the N- and C-terminal sequences; however, the relation-
ship between isomerization of these specific bonds and channel
opening remains to be determined. The observation that
FKBP12 also accelerates isomerization and increases channel
activity, but does not tightly bind or confer agonist-dependent
channel opening, supports the notion that the ability of FKBP52
to tightly bind TRPC1 is important for stimulus-dependent
regulation. Importantly, the physiological action of FKBP52 is
fundamentally different from the action of FKBP12, which
increases the spontaneous channel opening of TRPC1. Addi-
tional studies are required to fully understand the individual and
cooperative actions of FKBPs, Homer, and STIM1 in TRPC1
channel gating.
Immunosuppressant drugs, such as FK506, are widely used to
treat patients with autoimmune disorders and to prevent rejec-
tion of organ transplants. We have identified TRPC1 as an
endogenous substrate of PPIase activity of FKBPs. Our study
raises a potential concern that immunosuppressant drugs might
affect fetal nervous system development. Indeed, increased
abortion rate and preterm delivery has been noted for patients
using immunosuppressant drugs during pregnancy (Miniero
et al., 2002). On the other hand, given the observed dependence
of MAG signaling on the PPIase activity of FKBP52, the differen-
tial physiological function of FKBP12 versus FKBP52 identified in
our study may be therapeutically relevant. Accordingly, FKBP52
may provide a rational target for new medicinal chemistryNeuron 64, 471–483, November 25, 2009 ª2009 Elsevier Inc. 479
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protection in the adult central nervous system.
EXPERIMENTAL PROCEDURES
Reagents and Transfection
TRPC1 and Homer3 constructs were described previously (Xiao et al., 1998;
Yuan et al., 2003). FKBP12 and FKBP52 constructs were generously provided
by A. Srivastava (University of Florida). Point mutations were generated by
site-directedmutagenesis (Stratagene). The antibodies usedweremonoclonal
anti-myc and HRP-conjugated anti-myc and anti-HA (all from Santa Cruz
Biotech), rabbit polyclonal anti-Homer 3 (Xiao et al., 1998), monoclonal anti-
IP3 receptor type 3 (for co-IP; BD Biosciences), goat polyclonal anti-pan-IP3
receptor (for western blot; gift from A. Sharp), and rabbit polyclonal anti-
FKBP59/FKBP52 (Affinity BioReagents). Plasmid transfection was done using
calcium phosphate for 6 hr, washed once with 1X PBS, and replaced with
regular HEK293media. Cells were incubated at 37C for 36–48 hr. The amount
of cDNA transfected in a 100mmdish was 10 mg or less. These cells were used
for electrophysiology and co-IP analysis the following day.
Biochemistry
Protein binding assays were done as previously described (Yuan et al., 2003).
Transfected cells were harvested and lysed using 500 ml of binding buffer: 1X
PBS buffer containing 1 mM NaVO3, 10 mM NaPyrophosphate, 50 mM NaF
[pH 7.4], and 1% Triton X-100. The cell extracts were sonicated, and insoluble
material was spun down at 30,000 3 g for 20 min. For GST pull-down, GST-
FKBP52 was expressed in BL21 bacterial cells by growing a 400 ml culture
at 37C until A595 was 0.4–0.6. Cells were induced with 125 mM IPTG
for an additional hour, harvested, lysed in 10 ml of 1% Triton X-100 in 1X
PBS with 200 mg/ml PMSF, sonicated 3 3 10 strokes, and spun down at
12,000 3 g for 5 min. The supernatant was mixed 1:1 with slurry of GST-
agarose beads (Sigma) for 30 min at 4C. Beads were washed two times
with 1% Triton X-100 in 1X PBS and two times with 1X PBS. 50 ml of 1:1 slurry
of GST-FKBP52 beads were used per 100 ml cell extract and rocked for 2 hr at
4C. For co-IP experiments, 1 mg of purified antibody or 2 ml of crude antiserum
was added to 100 ml of cell extract and incubated for 1 hr at 4C. Then, 1:1
slurry of protein A or G sepharose 4B beads were added to the antibody-
extract mix and incubated for an additional hour at 4C. Beads were washed
3 3 10 min with binding buffer, and proteins were released from the beads
with SDS-loading buffer and subjected to western blot analysis.
For biotinylation assay, transfected cells were washed once with 1X PBS on
ice. EZ-Link Sulfo-NHS-SS-Biotin (0.5 mg/ml; Pierce) was added to the cells
for 30 min on ice. Afterward, the biotin was quenched with 50 mM glycine
on ice for 10–15 min. The cells were then processed as described above to
make cell extract. 50 ml of 1:1 slurry of immobilized avidin beads (Pierce)
were added to 100 ml of cell extract and incubated for 2 hr at 4C. Beads
were washed 3 3 10 min with binding buffer, and proteins were released
from the beads with SDS-loading buffer and subjected to western blot
analysis.
NMR Sample Preparation and Data Collection
Vectors for expression of TRPC1(14-30) and TRPC1(635-656) peptides were
constructed as GB1 fusion proteins using a modified QuikChange protocol
(Stratagene) to insert peptide sequences into pET30a vector containing GB1
with C-terminal 6xHis-tag cleavable with TEV protease (original vector con-
taining GB1 expression construct was a generous gift of G. Wagner, Harvard
Medical School). Following proteolytic cleavage the peptides were comprised
of the sequences corresponding to TRPC1(14-30) (GSHHHHHHGASSSLP
SSPSSSSSPN) and to TRPC1(635-656) (GSHHHHHHLSYFDDKCTLPPPFNII
PSPKT). Specifically, 15N-Leu-labeled TRPC1(14-30) was prepared as previ-
ously described (Muchmore et al., 1989). Uniformly 15N-labeled TRPC1(635-
656) was expressed in minimal M9 media supplemented with 15NH4Cl. GB1
fusion proteins were purified using Ni-Sepharose column (GE LifeSciences)
equilibrated with 500 mM NaCl, 50 mM Tris (pH 8.0), 1 ml/ml bME, and eluted
using 20–300mM Imidazole gradient in the same buffer. Following purification,
TRPC1 peptides were cleaved with AcTEV protease (Invitrogen) in 50mM Tris,480 Neuron 64, 471–483, November 25, 2009 ª2009 Elsevier Inc.0.5 mM EDTA, 2 mM DTT, and purified over ACE 5 C18-300 reverse phase
HPLC column (ACT) using 15%–35% acetonitrile gradient in H2O/0.1%
trifluoroacetic acid. TRPC1 peptides were desolvated using CentriVap con-
centrator (Labconco) and reconstituted in H2O.
All FKBP proteins were expressed in BL21(DE3) E. coli cells, induced with
1 mM isopropyl-b-D-thiogalactoside, and harvested after 3–4 hr. FKBP12
was purified using GSTrap column equilibrated with PBS buffer (pH 7.4) sup-
plemented with 1 ml/ml bME. GST-tag was cleaved with restriction grade
thrombin (Novagen) in 150 mM NaCl, 20 mM Tris (pH 8.4), 2.5 mM CaCl2,
2 mM DTT and removed using GSTrap column followed by benzamidine
Sepharose column equilibrated with PBS buffer (pH 7.4) to remove thrombin.
FKBP52 was purified using Ni-Sepharose column equilibrated with 500 mM
NaCl, 50 mM Tris (pH 8.0), 1 ml/ml bME and eluted using 20–300 mM Imidazole
gradient in the same buffer (all columns were purchased from GE LifeScien-
ces). Finally, FKBP proteins were buffer exchanged into 40 mM HEPES buffer
(pH 7.4), 5 mM TCEP.
NMR samples were prepared at 15N TRPC1 peptide/FKBPmolar ratios indi-
cated. Final sample buffer contained 40 mM HEPES (pH 6.8–7.1), 4 mM DTT,
5 mM TCEP, 10%D2O. Two-dimensional (2D)
1H-15N heteronuclear exchange
experiments (Farrow et al., 1994) were collected on Bruker Avance 800 MHz
spectrometer at 25C with mixing times varying from 0 ms to 600 ms. All
NMR spectra were processed with NMRPipe (Delaglio et al., 1995) and
visualized using NMRViewJ software (Johnson and Blevins, 1994).
Electrophysiology
TRPC1 current in HEK293 cells was measured with/without overexpression of
WT or mutant FKBP12/FKBP52 in whole-cell current recording configuration,
as described previously (Huang et al., 2006; Yuan et al., 2007). Briefly, the
pipette solution contained (in mM) 140 CsCl, 2 MgCl2, 1 ATP, 5 EGTA,
1.5 CaCl2 (free Ca
2+ at 70 nM), and 10HEPES at pH 7.2with CsOH, to eliminate
K+ current and prevent inhibition of the channels by high cytoplasmic Ca2+.
The bath solution contained (in mM) 140 NaCl or 140 NMDG-Cl, 5 KCl,
0.5 EGTA and 10 HEPES at pH 7.4 with NaOH or NMDG-OH. The current
was measured by ramp from 100 mV to +100 mV for 400 ms every 4 s
at holding potential 0 mV. The current recorded at 100 mV was used to
calculate current density as pA/pF. Multiple independent experiments were
used to obtain the mean ± SEM. Statistical significance was assessed using
Student’s t test.
Xenopus Embryo Injection and Spinal Neuron Culture
Blastomere injections of morpholino oligos or mRNAs encoding TRPC1,
FKBP52, FKBP12, or their mutant forms into early stages of Xenopus embryos
and culturing of spinal neurons from these injected embryos were performed
as previously described (Shim et al., 2005). Specifically, fertilized embryos
were injected at one- or two-cell stage, with a mixture of the morpholino
(10 ng/embryo) or mRNA (2–3 ng/embryo), and a lineage tracer. The following
DNA constructs were subcloned into the pCS2 vector (gif of D. Turner, Univer-
sity of Michigan) and used for in vitro transcription with the mMESSAGE
mMACHINE SP6 kit (Ambion): Myc-FKBP52-WT, Myc-FKBP52-FD67DV,
Myc-FKBP12-WT, Myc-FKBP12-D37L, HA-TRPC1-WT, HA-TRPC1-P645L,
HA-TRPC1-P645A, GFP-XTRPC1. A morpholino oligo directed against Xeno-
pus DCC (XDCC-MO) was designed with the following sequence: 50-CCAAGA
CAATTCTCCATATTTCAGC-30. Because of the presence of two FKBP52
homologs in the Xenopus, two morpholino oligos directed against Xenopus
FKBP52 (XFKBP52A, B-MO) were designed with the following sequences:
(XFKBP52A) 50-CGGTCTTCATCTCCTCGGCAGTCAT-30; (XFKBP52B) 50-CA
GGCTTCATCTCGTCAGCAGTCAT-30. Injected embryos at stage 22 were
used for cultures of spinal neurons as previous described (Shim et al., 2005).
Whole-Mount In Situ Hybridization, Immunostaining, and Confocal
Imaging
Full-length open reading frame region of XFKBP12 (accession number
AB006678) and the C-terminal open reading frame region of XFKBP52
(BamHI-stop codon fragment; accession number: NM_001091447) were
used to generate each specific digoxigenin-UTP-labeled anti-sense and sense
RNA probes. For whole-mount in situ hybridization, the labeled probes were
detected with alkaline phosphatase-conjugated anti- digoxigenin antibody
Neuron
PPIase FKBP52 Controls Axon Guidance through TRPC1(Fab fragments) and visualized with the BM purple AP substrate (Roche
Applied Science). For fluorescent in situ hybridization (FISH), cultures of spinal
neurons from stage 22 embryos were fixed in 4% PFA, 4% sucrose in PBS for
30 min at RT and hybridization and subsequent immunofluorescent detection
was performed as described previously (Leung et al., 2006) except that anti-
digoxigenin antibody and Alexa Fluor 568 secondary antibody (Jackson
ImmunoResearch, West Grove, PA) were used.
Embryos at stage 23–28 were fixed and processed for immunocytochem-
istry as previously described (Shim et al., 2005). Monoclonal antibody 3A10,
specific for commissural interneurons (Phelps et al., 1999; Serafini et al.,
1996), was obtained from the Developmental Studies Hybridoma Bank at
the University of Iowa and used at a dilution of 1:100. Secondary antibodies
were used at a dilution of 1:250. Confocal images of sagittal views of
embryos were taken with a Zeiss LSM 510 META system and Z series recon-
structions were processed with the Zeiss LSM image acquisition program.
A minimum of ten embryos was examined for each condition. Statistical
significance was assessed using the bootstrap test.
Ca2+ Imaging of Cultured Xenopus Spinal Neurons
Ca2+ imaging of growth cones of Xenopus spinal neurons was carried out as
previously described (Ming et al., 1997, 2002). Specifically, isolated Xenopus
spinal neurons were loaded with Fluo-4 AM (2 mM, Molecular Probes) in the
culture media without serum for 30 min at the room temperature, and rinsed
with the media for growth cone turning assay. Ca2+ imaging was performed
using a Zeiss 510 META system equipped with a 203 objective (NA 0.8). Exci-
tation was at 488 nm by argon laser and the emitted fluorescence was
collected at 500–560 nm. Fluorescence and bright-field images were simulta-
neously acquired at every 30 s with a frame scan. The fluorescence intensity of
each time point was measured over a fixed rectangular region of interest that
covers the entire growth cone and normalized to the average fluorescence
intensity that was measured during a 5 min baseline period (prior to netrin-1
application).
Primary Hippocampal Neuronal Cultures and Transfection
Hippocampal neurons were isolated from postnatal rats (P3–P5) and were
cultured on poly-L-lysine-coated coverslips as previously described (Goh
et al., 2008; Song et al., 2002). These neuronswere transfected with the Amaxa
transfection system following protocols from the manufacturer. Briefly, hippo-
campal neurons were isolated and 100 ml of nucleofector solution was added
to resuspend the cell pellet. Different expression constructs (1–5 mg) for GFP,
FKBP52-FD67DV, TRPC1-P645A, or a combination of TRPC1-P645A and
FKBP52-WT, were added to the cell suspension and then transferred to
cuvettes for electroporation. The cells were cultured in DMEM with 10% fetal
bovine serum for 24 hr before changing to serum-free neurobasal medium
(Goh et al., 2008).
Growth Cone Turning Assay
Microscopic gradients of netrin-1 (10 mg/ml in the pipette), MAG (150 mg/ml in
the pipette), Sema3A (50 mg/ml in the pipette), and GPI-1046 (100 mM in the
pipette) were produced as previously described (Lohof et al., 1992; Ming
et al., 1997, 2002; Zheng et al., 1994). Previous characterization showed that
at 100 mm away from the pipette tip the concentration of factors is about
1000-fold lower than that in the pipette and there is a 5%–10% concentration
gradient across the width of the growth cone (Lohof et al., 1992; Zheng et al.,
1994).Xenopus spinal neuronswere used at 14–20 hr after plating and neurons
with the lineage-tracer were identified under fluorescent microscope and used
for turning assay at the room temperature as previously described (Shim et al.,
2005). GFP+ hippocampal neurons were used at 48–72 hr after plating and
individual axon was identified as the longest neurite for turning assay at the
room temperature as previously described (Goh et al., 2008). The turning angle
was defined by the angle between the original direction of neurite extension
and a straight line connecting the positions of the center of the growth cone
at the onset and the end of the 30 min period. The rates of neurite extension
were calculated based on the net neurite extension during the turning
assay. Only those growth cones of isolated neurons with a net neurite
extension >5 mm over the 30 min period were included for analysis. Statistical
significance was assessed using the bootstrap test.SUPPLEMENTAL DATA
Supplemental Data include six figures and seven movies and can be found
with this article online at http://www.cell.com/neuron/supplemental/S0896-
6273(09)00736-3.
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